Encompass Health Corp (EHC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $13.83B
Last updated: Nov 17, 2026 at 11:05 AM ET
Encompass Health Corp (EHC) Earnings: Report Dates and Results
Encompass Health (EHC) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Encompass Health reported EPS of $1.52, above the $1.37 estimate. It beat the EPS estimate in each of the last 17 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
EHC has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 11.0% above the $1.46 reported for the quarter ended Dec 31, 2025.
EHC Earnings Call
The latest EHC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, EHC beat 35 and missed 5. Revenue for the quarter ended Sep 30, 2026 was $1.61B, up 8.8% from $1.48B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.52 | $1.37 | $1.25 - $1.41 | +10.95% | Beat | +23.6% | 12 | 8 up, 4 down | Oct 28, 2026 | $1.61B |
| Jun 30, 2026 | $1.55 | $1.48 | $1.42 - $1.51 | +4.73% | Beat | +10.7% | 12 | 1 up, 1 down | Aug 5, 2026 | $1.60B |
| Mar 31, 2026 | $1.60 | $1.49 | $1.38 - $1.53 | +7.38% | Beat | +16.8% | 12 | N/A | Apr 30, 2026 | $1.59B |
| Dec 31, 2025 | $1.46 | $1.30 | $1.23 - $1.35 | +12.31% | Beat | +24.8% | 12 | 3 up, 5 down | Feb 5, 2026 | $1.54B |
| Sep 30, 2025 | $1.23 | $1.19 | $1.15 - $1.23 | +3.36% | Beat | +19.4% | 13 | 7 up, 2 down | Oct 29, 2025 | $1.48B |
| Jun 30, 2025 | $1.40 | $1.21 | $1.14 - $1.31 | +15.70% | Beat | +26.1% | 12 | 1 up, 0 down | Aug 4, 2025 | $1.46B |
| Mar 31, 2025 | $1.37 | $1.19 | $1.14 - $1.26 | +15.13% | Beat | +22.3% | 10 | 0 up, 1 down | Apr 24, 2025 | $1.46B |
| Dec 31, 2024 | $1.17 | $1.02 | $0.96 - $1.13 | +14.71% | Beat | +23.2% | 13 | N/A | Feb 6, 2025 | $1.41B |
| Sep 30, 2024 | $1.03 | $0.94 | $0.89 - $1.01 | +9.57% | Beat | +19.8% | 13 | 0 up, 0 down | Oct 28, 2024 | $1.35B |
| Jun 30, 2024 | $1.11 | $1.01 | $0.95 - $1.09 | +9.90% | Beat | +16.8% | 12 | 1 up, 0 down | Aug 5, 2024 | $1.30B |
| Mar 31, 2024 | $1.12 | $0.94 | $0.88 - $1.01 | +19.15% | Beat | +27.3% | 11 | 1 up, 0 down | Apr 24, 2024 | $1.32B |
| Dec 31, 2023 | $0.95 | $0.82 | $0.76 - $0.87 | +15.85% | Beat | +8.0% | 10 | 1 up, 0 down | Feb 7, 2024 | $1.25B |
| Sep 30, 2023 | $0.86 | $0.77 | $0.72 - $0.84 | +11.69% | Beat | +28.4% | 10 | 1 up, 0 down | Oct 26, 2023 | $1.21B |
| Jun 30, 2023 | $0.95 | $0.74 | $0.70 - $0.79 | +28.38% | Beat | +6.7% | 12 | 0 up, 0 down | Aug 1, 2023 | $1.19B |
| Mar 31, 2023 | $0.88 | $0.71 | $0.67 - $0.76 | +23.94% | Beat | -9.3% | 12 | 0 up, 0 down | Apr 27, 2023 | $1.16B |
| Dec 31, 2022 | $0.88 | $0.84 | $0.80 - $0.87 | +4.76% | Beat | -9.3% | 10 | 0 up, 0 down | Feb 7, 2023 | $1.14B |
| Sep 30, 2022 | $0.67 | $0.64 | $0.23 - $0.72 | +4.69% | Beat | -35.0% | 12 | 0 up, 2 down | Oct 26, 2022 | $1.09B |
| Jun 30, 2022 | $0.89 | $0.96 | $0.88 - $1.07 | -7.29% | Miss | -23.9% | 13 | 0 up, 0 down | Aug 1, 2022 | $1.06B |
| Mar 31, 2022 | $0.97 | $0.92 | $0.80 - $1.00 | +5.43% | Beat | -7.6% | 12 | 1 up, 0 down | Apr 27, 2022 | $1.06B |
| Dec 31, 2021 | $0.97 | $1.05 | $0.98 - $1.09 | -7.62% | Miss | +4.3% | 11 | 0 up, 0 down | Feb 1, 2022 | $486.00M |
| Sep 30, 2021 | $1.03 | $1.06 | $1.01 - $1.12 | -2.83% | Miss | +32.1% | 12 | N/A | Oct 27, 2021 | $1.01B |
| Jun 30, 2021 | $1.17 | $0.98 | $0.84 - $1.02 | +19.39% | Beat | +277.4% | 11 | N/A | Jul 27, 2021 | $1.29B |
| Mar 31, 2021 | $1.05 | $0.82 | $0.70 - $0.89 | +28.05% | Beat | +20.7% | 11 | N/A | Apr 27, 2021 | $1.23B |
| Dec 31, 2020 | $0.93 | $0.85 | $0.82 - $0.91 | +9.41% | Beat | +9.4% | 14 | N/A | Jan 26, 2021 | $136.30M |
| Sep 30, 2020 | $0.78 | $0.74 | $0.52 - $0.88 | +5.41% | Beat | -16.1% | 14 | N/A | Oct 28, 2020 | $1.17B |
| Jun 30, 2020 | $0.31 | $0.33 | -$0.10 - $0.95 | -6.06% | Miss | -71.3% | 14 | N/A | Jul 27, 2020 | $1.07B |
| Mar 31, 2020 | $0.87 | $0.85 | $0.74 - $0.93 | +2.35% | Beat | -16.3% | 15 | N/A | Apr 28, 2020 | $1.18B |
| Dec 31, 2019 | $0.85 | $0.87 | $0.78 - $0.96 | -2.30% | Miss | +6.2% | 15 | N/A | Feb 6, 2020 | $1.18B |
| Sep 30, 2019 | $0.93 | $0.89 | $0.84 - $0.97 | +4.49% | Beat | +2.2% | 17 | N/A | Oct 28, 2019 | $1.16B |
| Jun 30, 2019 | $1.08 | $0.97 | $0.95 - $1.00 | +11.34% | Beat | +9.1% | 16 | N/A | Jul 29, 2019 | $1.14B |
| Mar 31, 2019 | $1.04 | $0.89 | $0.84 - $0.94 | +16.85% | Beat | +11.8% | 15 | N/A | Apr 25, 2019 | $1.12B |
| Dec 31, 2018 | $0.80 | $0.79 | $0.76 - $0.85 | +1.27% | Beat | +14.3% | 15 | N/A | Feb 7, 2019 | $1.10B |
| Sep 30, 2018 | $0.91 | $0.80 | $0.74 - $0.82 | +13.75% | Beat | +37.9% | 12 | N/A | Oct 29, 2018 | $1.07B |
| Jun 30, 2018 | $0.99 | $0.84 | $0.81 - $0.86 | +17.86% | Beat | +39.4% | 13 | N/A | Jul 25, 2018 | $1.07B |
| Mar 31, 2018 | $0.93 | $0.81 | $0.78 - $0.84 | +14.81% | Beat | +32.9% | 13 | N/A | Apr 26, 2018 | $1.05B |
| Dec 31, 2017 | $0.70 | $0.65 | $0.60 - $0.71 | +7.69% | Beat | -2.8% | 13 | N/A | Feb 26, 2018 | $1.01B |
| Sep 30, 2017 | $0.66 | $0.65 | N/A | +1.54% | Beat | +1.5% | N/A | N/A | Oct 26, 2017 | $981.60M |
| Jun 30, 2017 | $0.71 | $0.68 | N/A | +4.41% | Beat | +2.9% | N/A | N/A | Jul 31, 2017 | $966.40M |
| Mar 31, 2017 | $0.70 | $0.65 | N/A | +7.69% | Beat | +14.8% | N/A | N/A | Apr 27, 2017 | $957.10M |
| Dec 31, 2016 | $0.72 | $0.62 | N/A | +16.13% | Beat | +22.0% | N/A | N/A | Feb 21, 2017 | $885.30M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $5.46, up 23.3% from the year before. It was $2.67 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $5.46 | +23.3% |
| Dec 31, 2024 | $4.43 | +21.7% |
| Dec 31, 2023 | $3.64 | +6.7% |
| Dec 31, 2022 | $3.41 | -19.2% |
| Dec 31, 2021 | $4.22 | +46.0% |
| Dec 31, 2020 | $2.89 | -25.9% |
| Dec 31, 2019 | $3.90 | +7.4% |
| Dec 31, 2018 | $3.63 | +31.0% |
| Dec 31, 2017 | $2.77 | +3.7% |
| Dec 31, 2016 | $2.67 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,100 words across 16 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,134 | 16 | |
| 2026Q2 | Jun 30, 2026 | 8,091 | 17 | |
| 2026Q1 | Mar 31, 2026 | 9,443 | 15 | |
| 2025Q4 | Dec 31, 2025 | 8,229 | 16 | |
| 2025Q3 | Sep 30, 2025 | 7,236 | 16 | |
| 2025Q2 | Jun 30, 2025 | 6,500 | 15 | |
| 2025Q1 | Mar 31, 2025 | 7,743 | 14 | |
| 2024Q4 | Dec 31, 2024 | 7,581 | 14 |
2026Q3 Earnings Call
Opening remarks
Mark Miller Chief Investor Relations Officer Thank you, operator, and good morning, everyone. Thank you for joining Encompass Health's Third Quarter 2026 Earnings Call. Before we begin, if you do not already have a copy, the third quarter earnings release, supplemental information, and related Form 8-K filed with the SEC are available on our website at encompasshealth.com. On Page 2 of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we will make forward-looking statements, such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. Certain risks and uncertainties, like those relating to regulatory developments as well as volume, bad debt, and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations, are discussed in the company's SEC filings, including the earnings release and related Form 8-K, the Form 10-K for the year ended December 31, 2025, and the Form 10-Q for the quarters ended March 31, 2026, June 30, 2026, and September 30, 2026, when filed. We encourage you to read them. You are cautioned not to place undue reliance on the estimates, projections, guidance, and other forward-looking information presented, which are based on current estimates of future events and speak only as of today. We do not undertake a duty to update these forward-looking statements. Our supplemental information and discussion on this call will include certain non-GAAP financial measures. For such measures, reconciliation to the most directly comparable GAAP measure is available at the end of the supplemental information, at the end of the earnings release, and as part of the Form 8-K filed yesterday with the SEC, all of which are available on our website. I would like to remind everyone that we will adhere to the one-question and one-follow-up-question rule to allow everyone to submit a question. If you have additional questions, please feel free to put yourself back in the queue. With that, I'll turn the call over to President and Chief Executive Officer, Mark Tarr.
Mark Tarr President and CEO Thank you, and good morning, everyone. We're very pleased with our third quarter results. As revenue grew 8.9%, adjusted EBITDA increased 15.5% and adjusted EPS increased 23.6%. For the first nine months of 2026, revenue rose 9.2%, adjusted EBITDA increased 11.9% and adjusted EPS was up 17%. Based primarily on our Q3 results, we are again raising our guidance for 2026. We achieved these results while once again delivering outstanding patient outcomes. Our Q3 discharge-to-community rate was 84.7%, discharge-to-acute rate was 8.4%, and discharge-to-SNF rate was 6.2%.
Frequently Asked Questions About EHC
When is Encompass Health's next earnings date?
Encompass Health's next earnings report is expected for Feb 3, 2027.
Did EHC beat earnings estimates last quarter?
Yes. Encompass Health reported EPS of $1.52 for the quarter ended Sep 30, 2026, above the $1.37 estimate, a 10.95% surprise.
What EPS do analysts expect from EHC next quarter?
The consensus EPS estimate for Encompass Health for the quarter ending Dec 31, 2026 is $1.62 from 14 analysts, with estimates from $1.42 to $1.74.
How often does EHC beat earnings estimates?
Encompass Health beat the EPS estimate in each of the last 17 quarters, with an average surprise of +12.48%.
EHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts